Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Cytoreductive Surgery × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1594 Uterine Cervical Neoplasms 1297 Endometrial Neoplasms 724 Breast Neoplasms 382 Carcinoma, Ovarian Epithelial 367 Fallopian Tube Neoplasms 360 Uterine Cervical Dysplasia 238 Neoplasms 214 Uterine Neoplasms 156 Colorectal Neoplasms 156 Peritoneal Neoplasms 149 Vulvar Neoplasms 141 Lung Neoplasms 129 Pancreatic Neoplasms 123 Prostatic Neoplasms 117 Stomach Neoplasms 112 Recurrence 108 Papillomavirus Infections 100 Colonic Neoplasms 99 Melanoma 88 Sarcoma 86 Vaginal Neoplasms 85 Urinary Bladder Neoplasms 82 Head and Neck Neoplasms 78 Carcinoma, Non-Small-Cell Lung 76 Testicular Neoplasms 73 Esophageal Neoplasms 73 Neoplasm Metastasis 67 Rectal Neoplasms 63 Pelvic Neoplasms 57

Interventions

Fluorodeoxyglucose F18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05390021 2024-04-02

PET/MRI in Endometrial Cancer

Massachusetts General Hospital

Phase NA Withdrawn

Cytoreductive Surgery

Data powered by HemOnc (CC BY 4.0) Colophon ⚡